ECM1 promotes a Warburg effect-like metabolic phenotype (Lee, Nam, Oh, Lim, Lee, et al. 2015), cell proliferation, and trastuzumab resistance (Lee et al. 2014) by the activation of the EGFR pathway in breast cancers. The gene discussed is EGFR; the disease is breast cancer.